Literature DB >> 16863921

Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis.

Tracy A Balboni1, Reuben Gobezie, Harvey J Mamon.   

Abstract

Heterotopic ossification (HO) is a benign condition of abnormal formation of bone in soft tissue. HO is frequently asymptomatic, though when it is more severe it typically manifests as decreased range of motion at a nearby joint. HO has been recognized to occur in three distinct contexts-trauma, neurologic injury, and genetic abnormalities. The etiology of HO is incompletely understood. A posited theory is that HO results from the presence of osteoprogenitor cells pathologically induced by an imbalance in local or systemic factors. Individuals at high risk for HO development frequently undergo prophylaxis to prevent HO formation. The two most commonly employed modalities for prophylaxis are nonsteroidal anti-inflammatory drugs and radiation therapy. This review discusses HO pathophysiology, clinical features, and the role of radiotherapy for prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16863921     DOI: 10.1016/j.ijrobp.2006.03.053

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  81 in total

1.  Does a plastic drape reduce incidence of heterotopic ossification after hip resurfacing?

Authors:  John S Shields; Ali Mofidi; William G Ward; Riyaz H Jinnah
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

2.  The radiosensitivity of satellite cells: cell cycle regulation, apoptosis and oxidative stress.

Authors:  Vincent J Caiozzo; Erich Giedzinski; Mike Baker; Tatiana Suarez; Atefeh Izadi; Mary Lan; Jennie Cho-Lim; Bertrand P Tseng; Charles L Limoli
Journal:  Radiat Res       Date:  2010-08-02       Impact factor: 2.841

3.  Traumatic heterotopic ossification of the quadratus lumborum: a case report.

Authors:  Matthew D Karam; Todd O McKinley
Journal:  Iowa Orthop J       Date:  2008

4.  Satellite cells say NO to radiation.

Authors:  Jennie J Cho-Lim; Vincent J Caiozzo; Bertrand P Tseng; Erich Giedzinski; Mike J Baker; Charles L Limoli
Journal:  Radiat Res       Date:  2011-02-14       Impact factor: 2.841

5.  [Heterotopic ossifications in total hip arthroplasty: prophylaxis and therapy].

Authors:  J Schauwecker; F Pohlig; A Toepfer; H Gollwitzer; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

6.  Small molecule inhibition of non-canonical (TAK1-mediated) BMP signaling results in reduced chondrogenic ossification and heterotopic ossification in a rat model of blast-associated combat-related lower limb trauma.

Authors:  Amy L Strong; Philip J Spreadborough; Chase A Pagani; Ryan M Haskins; Devaveena Dey; Patrick D Grimm; Keiko Kaneko; Simone Marini; Amanda K Huber; Charles Hwang; Kenneth Westover; Yuji Mishina; Matthew J Bradley; Benjamin Levi; Thomas A Davis
Journal:  Bone       Date:  2020-07-02       Impact factor: 4.398

7.  Heterotopic ossifications: role of radiotherapy as prophylactic treatment.

Authors:  Maria Grazia Ruo Redda; Chiara De Colle; Lavinia Bianco; Andrea Ruggieri; Daniela Nassisi; Annalisa Rossi; Eva Gino; Claudia Airaldi
Journal:  Radiol Med       Date:  2018-02-03       Impact factor: 3.469

8.  Testicular Dose During Prophylaxis of Heterotopic Ossification with Radiation Therapy.

Authors:  Waleed F Mourad; John K Ma; Satyaseelan Packianathan; Weisi Yan; Sherif G Shaaban; Edward M Marchan; Lamiaa E Abdallah; Rei He; Paul N Mobit; Chunli Claus Yang; Srinivasan Vijayakumar
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

9.  Prophylaxis of heterotopic ossification - an updated review.

Authors:  Evan O Baird; Qian K Kang
Journal:  J Orthop Surg Res       Date:  2009-04-20       Impact factor: 2.359

10.  Risk of symptomatic heterotopic ossification following plate osteosynthesis in multiple trauma patients: an analysis in a level-1 trauma centre.

Authors:  Christian Zeckey; Frank Hildebrand; Philipp Mommsen; Julia Schumann; Michael Frink; Hans-Christoph Pape; Christian Krettek; Christian Probst
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-10-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.